Regulation
Medtronic’s next-gen pacemaker portfolio secures CE mark
Medtronic's Vitalis pacemaker portfolio has secured CE mark approval in Europe. The five-device portfolio uses conduction system pacing technology to stimulate the heart's native electrical pathways, enabling physicians to deliver therapy closer to the heart's natural conduction system.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network